We are live on ! Find out more
MME

Meag Munich Ergo Portfolio holdings

AUM $3.54B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
+3.68%
1 Year Est. Return
+20%
3 Year Est. Return
+82.79%
5 Year Est. Return
+144.54%
10 Year Est. Return
+335.02%
AUM
$2.25B
AUM Growth
-$275M
Cap. Flow
-$263M
Cap. Flow %
-11.69%
Top 10 Hldgs %
19.26%
Holding
376
New
60
Increased
72
Reduced
83
Closed
94

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$43.1M
2
NOC icon
Northrop Grumman
NOC
+$41M
3
UNH icon
UnitedHealth
UNH
+$27.7M
4
MU icon
Micron Technology
MU
+$26.3M
5
T icon
AT&T
T
+$25.4M

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$55.6M
2
CSCO icon
Cisco
CSCO
+$41.3M
3
IBM icon
IBM
IBM
+$34.6M
4
MDT icon
Medtronic
MDT
+$22.8M
5
PEG icon
Public Service Enterprise Group
PEG
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 16.69%
2 Healthcare 14.48%
3 Financials 12.72%
4 Industrials 10.51%
5 Consumer Staples 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
26
Merck
MRK
$315B
$19M 0.84%
310,516
+91,640
+42% +$5.58M
XOM icon
27
ExxonMobil
XOM
$611B
$18.8M 0.83%
233,112
-3,360
-1% -$275K
PM icon
28
Philip Morris
PM
$301B
$18.3M 0.81%
156,433
+139,292
+813% +$16.1M
MO icon
29
Altria Group
MO
$124B
$18.1M 0.81%
244,398
+152,121
+165% +$11.1M
MDT icon
30
Medtronic
MDT
$106B
$18M 0.8%
203,836
-270,059
-57% -$22.8M
ROP icon
31
Roper Technologies
ROP
$36.6B
$17.6M 0.78%
76,725
+13,086
+21% +$2.9M
CSX icon
32
CSX Corp
CSX
$94.3B
$16.7M 0.74%
933,642
+725,829
+349% +$12.4M
GILD icon
33
Gilead Sciences
GILD
$167B
$16.6M 0.74%
235,052
-95,870
-29% -$6.38M
META icon
34
Meta Platforms (Facebook)
META
$1.64T
$16.1M 0.72%
107,115
-93,812
-47% -$13.9M
AGN
35
DELISTED
Allergan plc
AGN
$16.1M 0.71%
66,043
-21,767
-25% -$5.11M
PYPL icon
36
PayPal
PYPL
$49.9B
$15.9M 0.7%
297,728
+153,299
+106% +$7.53M
TEL icon
37
TE Connectivity
TEL
$59.3B
$15.8M 0.7%
203,102
-87,989
-30% -$6.73M
BA icon
38
Boeing
BA
$169B
$15.4M 0.68%
+78,301
New +$14.6M
PEP icon
39
PepsiCo
PEP
$187B
$14.7M 0.65%
128,056
+51,913
+68% +$5.96M
PCG icon
40
PG&E
PCG
$38.1B
$14.1M 0.63%
213,827
+137,803
+181% +$9.28M
BABA icon
41
Alibaba
BABA
$276B
$14M 0.62%
99,500
+15,500
+18% +$1.91M
QRVO icon
42
Qorvo
QRVO
$7.54B
$13.8M 0.61%
215,715
+63,192
+41% +$4.52M
RTX icon
43
RTX Corp
RTX
$261B
$13.8M 0.61%
180,291
+74,950
+71% +$5.61M
GM icon
44
General Motors
GM
$68.6B
$13.6M 0.61%
392,151
+143,708
+58% +$4.88M
LOGI icon
45
Logitech
LOGI
$14.8B
$13.3M 0.59%
372,699
-39,872
-10% -$1.38M
BBY icon
46
Best Buy
BBY
$18B
$13.2M 0.59%
231,046
-37,426
-14% -$2M
FE icon
47
FirstEnergy
FE
$28.1B
$13.2M 0.59%
458,730
-63,453
-12% -$1.88M
BNS icon
48
Scotiabank
BNS
$110B
$13.1M 0.58%
217,656
UNP icon
49
Union Pacific
UNP
$179B
$13.1M 0.58%
121,489
+69,707
+135% +$7.6M
DB icon
50
Deutsche Bank
DB
$67.3B
$13M 0.58%
719,064
+156,184
+28% +$2.76M

Similar funds

Meag Munich Ergo's Q2 2017 Portfolio in Review

As of Q2 2017, Meag Munich Ergo held 376 positions worth $2.25B, down 11% from $2.53B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Meag Munich Ergo withdrew a net $263M in Q2 2017, closing 94 positions and reducing 83 holdings. Its most notable exit was UBS Group, an estimated $55.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Meag Munich Ergo opened a new position in Northrop Grumman worth $4.69M.

  • Meag Munich Ergo's largest Q2 2017 buy was Northrop Grumman: 164,027 shares worth $4.69M.
  • Meag Munich Ergo added most to Labcorp in Q2 2017, an estimated $43.1M increase.
  • Meag Munich Ergo's biggest Q2 2017 reduction was Cisco, cutting an estimated $41.3M.
  • Meag Munich Ergo fully exited UBS Group in Q2 2017, selling an estimated $55.6M.
  • Meag Munich Ergo's ten largest holdings make up 19% of its $2.25B portfolio in Q2 2017.
  • Meag Munich Ergo opened 60 new positions and closed 94 in Q2 2017.
  • Meag Munich Ergo's portfolio value fell 11% quarter-over-quarter to $2.25B.

Based on Meag Munich Ergo's 13F filing for Q2 2017, filed 24 Jul 2017.